CN108570487B - Method for increasing content of fructosyl mangiferin in plant extract - Google Patents
Method for increasing content of fructosyl mangiferin in plant extract Download PDFInfo
- Publication number
- CN108570487B CN108570487B CN201710257146.8A CN201710257146A CN108570487B CN 108570487 B CN108570487 B CN 108570487B CN 201710257146 A CN201710257146 A CN 201710257146A CN 108570487 B CN108570487 B CN 108570487B
- Authority
- CN
- China
- Prior art keywords
- mangiferin
- lactic acid
- fructosyl
- plant extract
- lactobacillus plantarum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- AEDDIBAIWPIIBD-ZJKJAXBQSA-N mangiferin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC=2C(=CC(O)=C(O)C=2)C2=O)C2=C1O AEDDIBAIWPIIBD-ZJKJAXBQSA-N 0.000 title claims abstract description 213
- 229940043357 mangiferin Drugs 0.000 title claims abstract description 108
- YWQSXCGKJDUYTL-UHFFFAOYSA-N Mangiferin Natural products CC(CCC=C(C)C)C1CC(C)C2C3CCC4C(C)(C)CCCC45CC35CCC12C YWQSXCGKJDUYTL-UHFFFAOYSA-N 0.000 title claims abstract description 107
- 238000000034 method Methods 0.000 title claims abstract description 37
- 239000000419 plant extract Substances 0.000 title claims description 25
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 58
- 238000006243 chemical reaction Methods 0.000 claims abstract description 43
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 37
- 241000894006 Bacteria Species 0.000 claims abstract description 33
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 33
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 33
- 235000014826 Mangifera indica Nutrition 0.000 claims abstract description 32
- 235000004936 Bromus mango Nutrition 0.000 claims abstract description 31
- 235000009184 Spondias indica Nutrition 0.000 claims abstract description 31
- 239000004310 lactic acid Substances 0.000 claims abstract description 29
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 29
- 230000036983 biotransformation Effects 0.000 claims abstract description 28
- 239000000348 glycosyl donor Substances 0.000 claims abstract description 27
- 239000000284 extract Substances 0.000 claims abstract description 19
- 230000006097 fructosylation Effects 0.000 claims abstract description 9
- 240000007228 Mangifera indica Species 0.000 claims abstract description 3
- 238000000855 fermentation Methods 0.000 claims description 19
- 230000004151 fermentation Effects 0.000 claims description 19
- 239000001963 growth medium Substances 0.000 claims description 18
- 239000006228 supernatant Substances 0.000 claims description 18
- 229930006000 Sucrose Natural products 0.000 claims description 15
- 239000005720 sucrose Substances 0.000 claims description 15
- 230000000694 effects Effects 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 12
- 239000008103 glucose Substances 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 125000000185 sucrose group Chemical group 0.000 claims description 7
- 241000186660 Lactobacillus Species 0.000 claims description 6
- 229940039696 lactobacillus Drugs 0.000 claims description 6
- 239000002609 medium Substances 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 238000013019 agitation Methods 0.000 claims 6
- 230000008021 deposition Effects 0.000 claims 1
- 241001093152 Mangifera Species 0.000 description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 239000007788 liquid Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000001888 Peptone Substances 0.000 description 8
- 108010080698 Peptones Proteins 0.000 description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
- 235000019319 peptone Nutrition 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 125000003147 glycosyl group Chemical group 0.000 description 5
- 108090000604 Hydrolases Proteins 0.000 description 4
- 102000004157 Hydrolases Human genes 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 108010059892 Cellulase Proteins 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229940106157 cellulase Drugs 0.000 description 3
- 239000012295 chemical reaction liquid Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 3
- 238000002514 liquid chromatography mass spectrum Methods 0.000 description 3
- 239000012263 liquid product Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 239000011942 biocatalyst Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 229910052564 epsomite Inorganic materials 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- -1 flavonoid compound Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 2
- CHUGKEQJSLOLHL-UHFFFAOYSA-N 2,2-Bis(bromomethyl)propane-1,3-diol Chemical compound OCC(CO)(CBr)CBr CHUGKEQJSLOLHL-UHFFFAOYSA-N 0.000 description 1
- XUSQTSSDINSWDI-UHFFFAOYSA-N 3,4,5,6-tetrahydroxy-1h-pyridin-2-one Chemical compound OC=1NC(=O)C(O)=C(O)C=1O XUSQTSSDINSWDI-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 241000186074 Arthrobacter globiformis Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- 241001524188 Glutamicibacter nicotianae Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010042889 Inulosucrase Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000012223 aqueous fraction Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- SVWLIIFHXFGESG-UHFFFAOYSA-N formic acid;methanol Chemical compound OC.OC=O SVWLIIFHXFGESG-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000000937 glycosyl acceptor Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 108010009004 proteose-peptone Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/58—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Use of lactic acid bacteria (Lactobacillus plantarum) with accession number BCRC 11697 for biotransformation reaction of mangiferin and glycosyl donor to produce fructosyl mangiferin. One embodiment of the use includes a method for increasing the content of fructosylation mangiferin in mango peel extract.
Description
The present application claims priority to taiwan patent application 106107637 entitled "method of increasing the content of fructosylated mangiferin in plant extracts" filed 2017, 3, 8, which is hereby incorporated by reference in its entirety.
Technical Field
The invention relates to a method for increasing the content of fructosyl mangiferin in mango peel extract by using lactic acid bacteria (Lactobacillus plantarum) with the preservation number of BCRC 11697, and application of the lactic acid bacteria (Lactobacillus plantarum) with the preservation number of BCRC 11697 in biotransformation reaction of mangiferin and glycosyl donor to generate the fructosyl mangiferin.
Background
Mangiferin is a carbon ketoside of tetrahydroxypyridone, belongs to a flavonoid compound of bisphenopyridone, and exists in various plants, such as mango trees, almond trees, northeast gentian, rhizoma anemarrhenae and the like. The molecular formula of mangiferin is as follows: c19H18O11Molecular weight: 422.3. mangiferin has various biological activities and pharmacological actions, such as antioxidation, anti-tumor, immunoregulation, anti-diabetes, anti-inflammation, etc. (Deng Jia, Li lan mushroom, Changchun Chinese medicine university, 2008, 24(4): 463 and 464.).
Although mangiferin has wide pharmacological activity, the solubility of mangiferin is poor, the development of the preparation of mangiferin is severely limited, and the solubility and the bioavailability of mangiferin need to be improved for convenient application.
For natural active ingredients with complex structures, the structural modification by chemical synthesis has the defects of low yield, poor reaction specificity, a plurality of byproducts and the like, and particularly, some reactions are difficult to realize by chemical means at present, but the defects of chemical synthesis can be made up by a biotransformation technology. Cantagrel et al (publication No. FR 2882762A 1) glycosylate mangiferin with glucosyltransferases from two strains of Leuconostoc mesenteroides to obtain glucosyl-beta- (1,6) -mangiferin (CASRN: 908570-23-0) when mangiferin is glycosyl acceptor and sucrose is glycosyl donor. When the Leuconostoc mesenteroides NRRL B-1299 strain is used as a biocatalyst, the glycosylation yield is 25 percent under the conditions of 0.4g/L mangiferin and 40g/L sucrose; when Leuconostoc mesenteroides NRRL 521-F strain is used as a biocatalyst, the glycosylation yield is 28% under the conditions of 0.4g/L mangiferin and 40g/L sucrose.
Chinese patent application publication No. CN 102863484A discloses a method for preparing fructosyl mangiferin, which comprises adding a substance with fructosyl hydrolase activity into a transformation liquid containing mangiferin to carry out biotransformation reaction, so that the mangiferin is transformed into the fructosyl mangiferin, wherein the transformation liquid contains mangiferin and glycosyl donor, the substance with fructosyl hydrolase activity is a fermentation liquid which is derived from Arthrobacter nicotianae and has the preservation number of CCTCC M2010164.
Purified mangiferin was used in the aforementioned patent applications of french publication No. FR 2882762 a1 and chinese publication No. CN 102863484 a for the fructosylation of mangiferin.
Disclosure of Invention
The invention mainly aims to provide a method for directly carrying out biotransformation reaction by taking mangiferin-containing plant extract as a substrate so as to convert the mangiferin into fructosyl mangiferin.
Another objective of the invention is to provide a suitable microorganism for carrying out a biotransformation reaction directly using mangiferin-containing plant extract as a substrate to convert the mangiferin into fructosyl mangiferin.
The invention also aims to provide a suitable microorganism and a method for improving the content of fructosyl mangiferin in mango peel extracting solution.
The invention relates to a method for increasing the content of fructosyl mangiferin in plant extract, which comprises the following steps:
providing a plant extract containing mangiferin; and
adding a glycosyl donor into the plant extract, and performing biotransformation reaction in the presence of a substance with fructosyl hydrolase activity to convert the mangiferin into fructosyl mangiferin, wherein the substance with fructosyl hydrolase activity is produced by fermentation of Lactobacillus (Lactobacillus plantarum) with accession number of BCRC 11697.
Preferably, the plant extract is mango peel extract.
Preferably, the glycosyl donor is sucrose or glucose. More preferably, the glycosyl donor is sucrose.
Preferably, the lactic acid bacterium (Lactobacillus plantarum) with the accession number BCRC 11697 is added to the plant extract.
Preferably, a fermentation broth of the lactic acid bacterium (Lactobacillus plantarum) deposited under accession number BCRC 11697 is added to the plant extract.
Preferably, a fermentation supernatant of the lactic acid bacterium (Lactobacillus plantarum) deposited under accession number BCRC 11697 is added to the plant extract.
Preferably, fructosylase purified from a fermentation supernatant of the lactic acid bacterium (Lactobacillus plantarum) deposited under accession number BCRC 11697 is added to the plant extract.
Preferably, the biotransformation reaction is carried out in a lactic acid bacteria culture medium at 20-40 deg.C and no stirring or no more than 400rpm for 0.5-96 hr, and based on 100mL of the culture medium, the amount of the glycosyl donor is 1-20 g, the amount of the plant extract is 1-60mL, and the amount of the lactic acid bacteria is 105~107CFU/mL。
The invention provides an application of Lactobacillus (Lactobacillus plantarum) with a preservation number of BCRC 11697 in biotransformation reaction of mangiferin and glycosyl donor to generate fructosyl mangiferin.
The invention provides an application of a fermentation liquid of Lactobacillus (Lactobacillus plantarum) with a preservation number of BCRC 11697 in biotransformation reaction of mangiferin and glycosyl donor to generate fructosyl mangiferin.
The invention provides an application of mangiferin and glycosyl donor in biotransformation reaction of mangiferin and glycosyl donor by using a fermentation supernatant of Lactobacillus (Lactobacillus plantarum) with a preservation number of BCRC 11697 to generate fructosyl mangiferin.
The invention provides a use of a fructosylation enzyme purified from a fermentation supernatant of lactic acid bacteria (Lactobacillus plantarum) with the accession number BCRC 11697 for carrying out a bioconversion reaction of mangiferin and a glycosyl donor to produce fructosylation mangiferin.
Drawings
Fig. 1 is an ultraviolet absorption spectrum of a fructosyl mangiferin standard substance at different wavelengths.
FIG. 2 shows the ultraviolet absorption spectra of the supernatant after the conversion with Lactobacillus plantarum lactic acid bacteria and the centrifugation removal of the bacteria according to the method of the invention at different wavelengths.
FIG. 3 is a liquid chromatography mass spectrometry (LC-MS) spectrum of a fructosyl mangiferin standard.
FIG. 4 is a LC-MS spectrum of supernatant after the Lactobacillus plantarum Lactobacillus is transformed and centrifuged to remove the bacteria according to the method of the present invention.
Figure 5 shows the effect of different glycosyl donors on the conversion of mangiferin to fructosylated mangiferin by strains of the invention.
Figure 6 shows the results of comparing the sucrose glycosyl at different levels (ratios) to the efficiency of the strains of the invention to convert mangiferin to fructosylated mangiferin.
Detailed Description
A preferred embodiment accomplished in accordance with the present invention comprises a method for increasing the fructosylation mangiferin content in a mango peel extract, essentially comprising adding a glycosyl donor to the mango peel extract, performing a bioconversion reaction in the presence of a substance having fructosyl converting enzyme activity, to convert mangiferin contained in the mango peel extract to fructosylation mangiferin, wherein the substance having fructosyl converting enzyme activity is produced by fermentation of lactic acid bacteria (Lactobacillus plantarum) deposited under accession number BCRC 11697. The method can enable mango peel to be glycosylated with mangiferin more efficiently, so that the problem that when mango is made into fruit juice, dried mango or canned mango pulp during mango production, the mango peel is out of the place, environmental pollution is reduced, and the purposes of full fruit utilization and mango economic value improvement are achieved.
A suitable method for preparing mango peel extract for use in the present invention includes (but is not limited to) the following steps: cleaning and crushing mango peel;
then, using celloferment (Cellulase) to perform homogenization treatment at room temperature to 50 ℃ for 60-180 minutes; drying at 60 deg.C to remove water, and pulverizing into powder; mixing the powder with a polar solvent at a ratio of 1: 5-1: 20g/mL, extracting at 50 deg.C preferably under ultrasonic oscillation such as 125-500W/L for 60 min at room temperature to 50 deg.C, and removing the polar solvent to obtain Mangiferin-containing pericarp extract.
Suitable polar solvents are, for example, water, C1-C3 alcohols and mixtures thereof, preferably ethanol in water, for example 50% (v/v) ethanol.
The mango peel extracting solution is a matrix material source for transforming mangiferin by using microorganisms, and the invention uses Cellulase (cellulose) or other enzymes capable of decomposing the wall of a plant cell to promote the extraction benefit of substances in the cell. In addition, ultrasonic oscillation is adopted during extraction, so that the extraction effect of flavonoid substances in the mango peel can be further improved. According to the method, parameters such as solvent ratio, ultrasonic power, extraction time and the like are discussed, 50% (v/v) ethanol water solution is obtained, the ultrasonic power is 500W/L, the extraction is carried out for 60 minutes at 50 ℃, and mango polyphenol with high content and mango peel extract rich in mangiferin can be obtained. In a preferred embodiment, the content of fructosyl mangiferin in the mango peel extract is 18 μ g/mL by HPLC quantitative analysis.
One suitable glycosyl donor for use in the present invention includes, but is not limited to, sucrose, glucose and fructose, with sucrose or glucose being preferred and sucrose being most preferred.
Preferably, a fermentation supernatant of the lactic acid bacterium (Lactobacillus plantarum) deposited under the accession number BCRC 11697 in the biotransformation reaction of the method of the present invention is added to the mango peel extract. A suitable medium formulation for the lactic acid bacteria of BCRC 11697 comprises: 2-80 g/L glucose, 5-50 g/L peptone and KH2PO4 0.4~4g/L,MgSO4·7H2O 0.05~1.0g/L,MnSO4·H20.01-0.1 g/L of O and 6-8 of pH.
The process of the present invention preferably further comprises purifying the product of the biotransformation reaction with increased fructosyl mangiferin content, for example by means of resin purification to obtain the aqueous fraction thereof. The water phase can be used as antioxidant directly or after concentrating, and can be added into cosmetic such as sunscreen emulsion or cosmetic. Optionally, the purified fructosylated mangiferin can also be obtained by separating the fructosylated mangiferin from the liquid fraction by known purification methods.
Examples
Materials and methods
Materials and methods
1. Culture medium formula and strain culture
(1) Lactobacillus culture medium (MRS medium)
MRS culture medium formula: sequentially adding 1g of monthly peptone (Proteose peptone) No.3, 1g of Beef extract (Beef extract), 0.5g of Yeast extract (Yeast extract), 2g of glucose (Dextrose), 0.1g of Tween 80 surfactant, 0.2g of Ammonium citrate (Ammonium citrate), 0.5g of CH3COONa, 10mg MgSO4·7H2O、5mg MnSO4·H2O、0.2g K2HPO4Then, the volume was adjusted to 100mL by adding water, and the pH was adjusted to 6.5 and then autoclaved. After the strain is activated in the culture medium, the inoculation amount of the strain is 10 percent of the volume of the culture medium. The growth temperature was 37 ℃ and pH 6.5, and the OD of the bacterial solution was obtained by static culture (0rpm)600When 10 days have elapsed, the cells were centrifuged to remove the cells to obtain a supernatant.
(2) Bacteria culture medium (Nutrient medium)
0.3g of Beef extract (Beef extract), 0.5g of peptone (peptone) were added in this order, followed by addition of water to make the volume 100mL, adjustment of the pH to 7.0 and autoclaving. After the strain is activated in the culture medium, the inoculation amount of the strain is 10 percent of the volume of the culture medium. The growth temperature is 26 ℃, pH 7.0, 100rpm culture, OD of bacteria liquid600When 10 days have elapsed, the cells were centrifuged to remove the cells to obtain a supernatant.
(3) Yeast culture medium (YPD medium)
2g of peptone (peptone), 2g of glucose (Dextrose), and 1g of Yeast extract (Yeast extract) were sequentially added, followed by autoclaving after supplementing water to make the volume 100 mL. After the strain is activated in the culture medium, the inoculation amount of the strain is 10 percent of the volume of the culture medium. The growth temperature is 25 ℃, pH 7.0, 100rpm culture, OD of bacterial liquid600When 10 days have elapsed, the cells were centrifuged to remove the cells to obtain a supernatant.
(4) Filamentous fungus culture medium (malt extract)
2.0g of Glucose (Glucose), 1.0g of peptone (peptone) and 2.0g of wort (Malt extract) were added in this order, followed by autoclaving after adding water to make the volume 100 mL. After the strain is activated in the culture medium, the inoculation amount of the strain is 10 percent of the volume of the culture medium. Culturing at 24-30 deg.C, pH 7.0 and 100rpm to obtain bacterial liquid OD600When 10 days have elapsed, the cells were centrifuged to remove the cells to obtain a supernatant.
2. Preparation of mango peel extract
Cleaning and crushing mango peel, adding Cellulase (cellulose) according to the proportion of 2% (W/W), carrying out hydrolysis reaction for 180 minutes at 50 ℃, drying in a 60 ℃ oven to remove water, homogenizing and crushing into mango peel powder, carrying out an ultrasonic-assisted extraction process under the conditions of 50% (v/v) ethanol, a material-liquid ratio of 1:5, an ultrasonic power of 500W/L, an ultrasonic frequency of 40Hz and an extraction temperature of 50 ℃, extracting for 60 minutes, and removing ethanol in a 60 ℃ vacuum oven to obtain a mangiferin-containing peel extract.
3. Fructosylation mango biotransformation reaction:
adding the bacterial liquid, the mango peel extracting solution and an aqueous solution of a glycosyl donor into water or Phosphate Buffered Saline (PBS), and carrying out biotransformation reaction at 37 ℃ to convert mangiferin into fructosyl mangiferin, wherein the reaction time is 96 hours. The addition amount of the bacterial liquid is 10% of the volume of the whole conversion reaction liquid, the addition amount of the mango peel extracting solution is 10% of the volume of the whole conversion reaction liquid, and the addition amount of the water solution of the glycosyl donor is 0-20 g glycosyl (0-20 w/v%) in each 100mL of the conversion reaction liquid. Analyzing the content of the fructosyl mangiferin by using a high performance liquid chromatography.
The above biotransformation reaction was repeated except that the above-mentioned bacterial solution was not added, and data of a control group for comparison was obtained.
4. High Performance Liquid Chromatography (HPLC) quantification of fructosylated mangiferin
Precisely weighing 1mg of a Fructosylated mangiferin (glycosylated mangiferin) standard product, dissolving the product with 50% ethanol, and preparing 1mL of a reference solution containing 0.01-1 mg of the product. The test sample was a liquid after completion of the conversion reaction, centrifuged at 8000rpm for 5 minutes, the supernatant was collected, and 1mL of the sample solution was subjected to HPLC Atlantis T3 column (C18,4.6mm in diameter. times.250 mm,5 μm in diameter), the mobile phase solution was acetonitrile/l% glacial acetic acid solution (15:85), the reaction temperature was 25 ℃, the flow rate was set to 1.0mL/min, the detector wavelength was set to 254nm, and the injection sample volume was 20 μ l. The sample was taken out with a syringe, filtered with 0.22um PVDF, and subjected to HPLC quantitative analysis (guolinling, zuo, liu wei, koreant, billow, 2013, measurement of mangiferin content in mango leaves, 32 (1): 43-45, university of tianjin chinese medicine).
5. Liquid chromatography-mass spectrometry (LC-MS) identification of fructosyl mangiferin
A ZORBAX Eclipse XDB-C18Narrow Bore RR column (2.1X150mm,3.5 μm) was used. The mobile phases were 0.02% aqueous formic acid and 0.02% methanoic acid, respectively, with flow rates set at 0.2 ml/min. The elution (elution) procedure was as follows:
time (min.) | 0.02% aqueous formic acid (%) | 0.02% formic acid methanol solution (%) |
0 | 95 | 5 |
2.5 | 95 | 5 |
50 | 0 | 100 |
70 | 0 | 100 |
The spectra were obtained using a Micromass ZQ mass spectrometer with electrospray ionization (ESI-MS) at Cone voltages of 10V, 15V, 20V, 35V, 50V.
Results and discussion
1. Screening of strains with the potential to convert mangiferin to fructosyl mangiferin
Potential strains with fructosylase activity (beta-fructofuranosidase and fructosyl transferase) or Tyrosinase (Tyrosinase) inhibition activity are preliminarily screened from lactic acid bacteria, yeasts and filamentous fungi in a biological resource storage and research center (BCRC) online catalog of the institute of food industry development of the financial group legal (Taiwan, New bamboo city), and the potential strains respectively comprise 19 potential strains of 2 strains of bacteria, 1 strain of yeasts, 10 strains of lactic acid bacteria and 6 strains of filamentous fungi. The strains were activated as described above, subjected to biotransformation reaction, and analyzed for their fructosyl mangiferin content by high performance liquid chromatography, and the fruits are listed in Table one. From the results in the table, it can be seen that four of them have potential, 2 strains of the bacteria Arthrobacter nicotinoide BCRC 11219, Arthrobacter globiformis BCRC 10598, 1 strain of the yeast Saccharomyces cerevisiae BCRC 20855, and 1 strain of the lactic acid bacterium Lactobacillus plantarum BCRC 11697, respectively. Based on the industrial applicability, GRAS strains and those with high fructosyl mangiferin content are used as targets, and therefore, Lactobacillus plantarum is screened as a potential strain for the invention.
TABLE I screening of potential strains for converting mangiferin into fructosyl mangiferin
Note: not measured n.d ═ d ═
2. Analysis of the ability of different strains of Lactobacillus plantarum to transform into fructosylated mangiferin
Collecting different L.plantarum strains, namely L.plantarum BCRC 11697, BCRC 12327, BCRC 14059, BCRC 15478, BCRC 17178 and BCRC 17638, activating the strains according to the method, performing biotransformation reaction, and analyzing the content of the fructosyl mangiferin by high performance liquid chromatography, wherein the fruits are listed in Table two. As shown in Table two, Lactobacillus plantarum BCRC 11697 has the best ability to convert into fructosyl mangiferin.
TABLE II, results of different Lactobacillus plantarum using mango peel extract as substrate, converting to fructosyl mangiferin
3. Ultraviolet absorption spectrum analysis result
FIGS. 1 and 2 are ultraviolet absorption spectra of 50 μ g/mL fructosylmangiferin standard solution and 200.0-400.0 nm of liquid product obtained by biotransformation reaction with Lactobacillus plantarum BCRC 11697, respectively. As can be seen from FIGS. 1 and 2, the fructosyl mangiferin standard substance has the same peak shape as the absorption curve of the liquid product obtained by the biotransformation reaction of Lactobacillus plantarum BCRC 11697, and has absorption peaks at the wavelengths of 238 nm, 254nm, 317 nm and 367nm, wherein the absorption peak at 254nm is strongest. Therefore, 254nm is used as the measuring wavelength of the fructosyl mangiferin standard product and the fructosyl mangiferin content of the liquid product obtained after the biotransformation reaction.
LC-MS analysis results
FIGS. 3 and 4 are LC-MS spectra of fructosyl mangiferin standard and supernatant obtained by centrifugation of bacterial cells after biotransformation reaction with Lactobacillus plantarum BCRC 11697, respectively. Comparing the LC-MS spectra in FIG. 3 and FIG. 4, it can be seen that the transformed product obtained by the biotransformation reaction of the present invention contains fructosyl mangiferin.
5. Comparing the effects of different glycosyl donors on the transformation of strains to produce fructosyl mangiferin
The results of the biotransformation reactions using Lactobacillus plantarum BCRC 11697 and different glycosyl donors (sucrose, glucose, fructose) in the previous method are shown in FIG. 5, from which it can be seen that sucrose has the highest conversion efficiency of fructosylated mangiferin, and that the fructosylated mangiferin content can reach a relatively high point of 35. mu.g/mL within 24 hours of conversion time.
6. Discussing the comparison of conversion efficiency of sucrose glycosyl to fructosyl mangiferin in different proportions
FIG. 6 is a graph comparing the effect on the conversion efficiency of fructosylated mangiferin with the addition of 0.5% to 20% (w/v) sucrose glycosyl. The control group was transformed by adding 0.5% of sugar group without adding Lactobacillus plantarum BCRC 11697 strain solution. The content of the fructosyl mangiferin is 25 mu g/mL at 0 hour. From the results of fig. 6, it can be seen that the content of fructosylation mangiferin can reach a relatively high value at 6 hours when the biotransformation reaction is carried out between the sucrose group high concentration (20%) and the sucrose group low concentration (0.5%). In addition, the group with 0.5% sucrose group has better average conversion efficiency than other high concentration groups. In figure 6, the conditions of 0.5% glycosyl and 6 hours of conversion have the highest fructosyl mangiferin content, which can reach 57 mu g/mL and is improved by more than 1 time than 25 mu g/mL of the control group.
Any numerical value mentioned in this specification, if there is only a two unit interval between any lowest value and any highest value, includes all values from the lowest value to the highest value incremented by one unit at a time. For example, if it is stated that the amount of a component, or a value of a process variable such as temperature, pressure, time, etc., is 50 to 90, it is meant in this specification that values of 51 to 89, 52 to 88 … …, and 69 to 71, and 70 to 71, etc., are specifically enumerated. For non-integer values, units of 0.1, 0.01, 0.001, or 0.0001 may be considered as appropriate. These are only some specifically named examples. In a similar manner, all possible combinations of numerical values between the lowest value and the highest value enumerated are to be considered to be disclosed in this application.
It should be noted that the above-mentioned embodiments are only for explaining the present invention, and do not constitute any limitation to the present invention. The present invention has been described with reference to exemplary embodiments, but the words which have been used herein are words of description and illustration, rather than words of limitation. The invention can be modified, as prescribed, within the scope of the claims and without departing from the scope and spirit of the invention. Although the invention has been described herein with reference to particular means, materials and embodiments, the invention is not intended to be limited to the particulars disclosed herein, but rather extends to all other methods and applications having the same functionality.
Claims (15)
1. A method for increasing the fructosyl mangiferin content in a plant extract comprises the following steps:
providing a plant extract containing mangiferin; and
adding a glycosyl donor into the plant extract, and carrying out biotransformation reaction in the presence of a substance with fructosyl enzyme activity to convert the mangiferin into fructosyl mangiferin, wherein the substance with fructosyl enzyme activity is generated by fermentation of Lactobacillus (Lactobacillus plantarum) with the deposition number of BCRC 11697.
2. The method of claim 1, wherein the plant extract is mango peel extract.
3. The method of claim 1, wherein the glycosyl donor is sucrose or glucose.
4. The method of claim 1, wherein the glycosyl donor is sucrose.
5. The method according to any one of claims 1 to 4, wherein the lactic acid bacterium (Lactobacillus plantarum) deposited under accession number BCRC 11697 is added to the plant extract.
6. The method of any one of claims 1-4, wherein a fermentation broth of the lactic acid bacterium (Lactobacillus plantarum) deposited under accession number BCRC 11697 is added to the plant extract.
7. The method of any one of claims 1-4, wherein a supernatant of a fermentation broth of lactic acid bacteria (Lactobacillus plantarum) deposited under accession number BCRC 11697 is added to the plant extract.
8. The method of any one of claims 1 to 4, wherein fructosylase purified from a supernatant of a fermentation broth of the lactic acid bacterium (Lactobacillus plantarum) deposited under accession number BCRC 11697 is added to the plant extract.
9. The method of claim 5, wherein the bioconversion reaction is performed in a lactic acid bacteria culture medium at 20-40 ℃ and no agitation or agitation speed no greater than 400rpm for 0.5 to 96 hours, and the amount of the glycosyl donor is 1-20 g, the amount of the plant extract is 1-60mL, and the amount of the lactic acid bacteria is 10 mL, based on 100mL of the culture medium5~107CFU/mL。
10. The method of claim 6, wherein the bioconversion reaction is performed in a lactic acid bacteria medium at 20-40 ℃ and no agitation or agitation speed no greater than 400rpm for 0.5 to 96 hours, and the amount of the glycosyl donor is 1-20 grams, the amount of the plant extract is 1-60mL, and the amount of the fermentation broth is 1-60mL, based on 100mL of the medium.
11. The method of claim 7, wherein the bioconversion reaction is performed in a lactic acid bacteria medium at 20-40 ℃ and no agitation or agitation speed no greater than 400rpm for 0.5 to 96 hours, and the amount of the glycosyl donor is 1-20 grams, the amount of the plant extract is 1-60mL, and the amount of the fermentation supernatant is 1-60mL, based on 100mL of the medium.
12. Use of lactic acid bacteria (Lactobacillus plantarum) with accession number BCRC 11697 for biotransformation reaction of mangiferin and glycosyl donor to produce fructosyl mangiferin.
13. Use of a fermentation broth of lactic acid bacteria (Lactobacillus plantarum) with accession number BCRC 11697 for biotransformation reaction of mangiferin and glycosyl donor to produce fructosyl mangiferin.
14. Use of a fermentation supernatant of lactic acid bacteria (Lactobacillus plantarum) with accession number BCRC 11697 for the bioconversion of mangiferin and a glycosyl donor to produce fructosylated mangiferin.
15. Use of a fructosylation enzyme purified from a fermentation supernatant of a lactic acid bacterium (Lactobacillus plantarum) having accession number BCRC 11697 for the bioconversion of mangiferin and a glycosyl donor to produce fructosylated mangiferin.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW106107637A TWI626313B (en) | 2017-03-08 | 2017-03-08 | Method for increasing content of fructosylized mangiferin in plant extract |
TW106107637 | 2017-03-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108570487A CN108570487A (en) | 2018-09-25 |
CN108570487B true CN108570487B (en) | 2021-07-27 |
Family
ID=63256090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710257146.8A Active CN108570487B (en) | 2017-03-08 | 2017-04-19 | Method for increasing content of fructosyl mangiferin in plant extract |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN108570487B (en) |
TW (1) | TWI626313B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2882762A1 (en) * | 2005-03-04 | 2006-09-08 | Biolog Vegetale Yves Rocher Sa | Glycosylation of mangiferine by biocatalyst, useful in cosmetic field to protect skin comprises contacting mangiferine with a glycosyltransferase enzyme, in the presence of a sugar donor |
CN102443027A (en) * | 2010-10-13 | 2012-05-09 | 南京工业大学 | Fructosyl puerarin and preparation method and application thereof |
CN102732456A (en) * | 2012-06-06 | 2012-10-17 | 南京工业大学 | Organic solvent-resistant glycosidase Fru6, and mutant and application thereof |
WO2013004086A1 (en) * | 2011-07-06 | 2013-01-10 | 南京工业大学 | Fructosylated mangiferin and preparation method therefor and use thereof |
CN105349508A (en) * | 2013-10-28 | 2016-02-24 | 光明乳业股份有限公司 | Application of novel fructosidase coding gene |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2220103B1 (en) * | 2007-11-22 | 2015-04-08 | Hainan Deze Drug Research Co., Ltd | Novel mangiferin calcium salts, the method for its preparation and its use |
-
2017
- 2017-03-08 TW TW106107637A patent/TWI626313B/en active
- 2017-04-19 CN CN201710257146.8A patent/CN108570487B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2882762A1 (en) * | 2005-03-04 | 2006-09-08 | Biolog Vegetale Yves Rocher Sa | Glycosylation of mangiferine by biocatalyst, useful in cosmetic field to protect skin comprises contacting mangiferine with a glycosyltransferase enzyme, in the presence of a sugar donor |
CN102443027A (en) * | 2010-10-13 | 2012-05-09 | 南京工业大学 | Fructosyl puerarin and preparation method and application thereof |
WO2013004086A1 (en) * | 2011-07-06 | 2013-01-10 | 南京工业大学 | Fructosylated mangiferin and preparation method therefor and use thereof |
CN102732456A (en) * | 2012-06-06 | 2012-10-17 | 南京工业大学 | Organic solvent-resistant glycosidase Fru6, and mutant and application thereof |
CN105349508A (en) * | 2013-10-28 | 2016-02-24 | 光明乳业股份有限公司 | Application of novel fructosidase coding gene |
Also Published As
Publication number | Publication date |
---|---|
CN108570487A (en) | 2018-09-25 |
TW201833327A (en) | 2018-09-16 |
TWI626313B (en) | 2018-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Monti et al. | Generation of an α‐L‐rhamnosidase library and its application for the selective derhamnosylation of natural products | |
TWI558722B (en) | Use of extraction residue of yeast extract | |
CN114478565B (en) | Monascin A with glycosidase activity inhibiting and immunoregulatory activity and preparation method thereof | |
Zhang et al. | Effect of submerged and solid-state fermentation on pigment and citrinin production by Monascus purpureus | |
KR20160086498A (en) | Strain having ginsenoside bioconversion activity and manufacturing method of fermented red ginseng extract using the same | |
CN111617120B (en) | Preparation method of ginseng cordyceps sinensis fermentation extract | |
KR102258788B1 (en) | Novel Aspergillus niger C2-2 isolated from Nu-ruk producing ginsenoside compound K biotransformation enzyme and use thereof | |
CN108570487B (en) | Method for increasing content of fructosyl mangiferin in plant extract | |
US7341855B2 (en) | Plant mangrove-associated fungus Curvularia lunata and a simple and efficient method of obtaining high yield of pure mannitol from the same | |
CN114478564B (en) | Monascin C with glycosidase activity inhibiting and immunoregulatory activity and preparation method thereof | |
CN115216511B (en) | Method for preparing rare saponin by fermenting and converting notoginsenoside R1 with lactobacillus plantarum | |
CN113293106B (en) | Fungus of genus Filobasidium of class Ascomycetes and application thereof | |
CN113502230B (en) | Hericium erinaceus strain and culture method thereof, hericium erinaceus-ginseng bidirectional solid fermentation method and method for efficiently converting rare ginsenoside | |
CN108795773B (en) | Musk mould strain and perfume prepared from same | |
Lucas et al. | Improved production of pharmacologically-active sclerotiorin by Penicillium sclerotiorum | |
CN109234347B (en) | Method for converting protopanaxatriol saponin to obtain C25-OH derivative | |
CN114292280A (en) | Monascus B with glycosidase inhibiting activity and immunoregulation activity and preparation method thereof | |
Miyazaki et al. | Trehalose accumulation by a basidiomycotinous yeast, Filobasidium floriforme | |
CN113717860A (en) | Application of Talaromyces flavidus in conversion of panax notoginseng saponins into low-polarity ginsenoside | |
Subramanian et al. | Improved inulinase activity by Penicillium purpurogenum grown in microwave pretreated coffee spent by L16 orthogonal design of experiment | |
Chen et al. | Optimization of limonin invertase production by scaling up Aspergillus tubingensis UA13 fermentation to a 5-l scale | |
CN105199966B (en) | A kind of conversion ginsenoside Rb1 produces aspergillus and the application of Rd | |
CN115478026B (en) | Radioresistant coccus and application thereof | |
CN110713935B (en) | Aspergillus niger and pectinase for high yield of narrow-distribution pectin oligosaccharides and application thereof | |
CN109810906B (en) | Endophytic fungi and application thereof in fermentation preparation of phenolic acid compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |